share_log

UBS Maintains Buy on Aemetis, Lowers Price Target to $7.75

Benzinga ·  Aug 19 22:02  · Ratings

UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $8.25 to $7.75.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment